Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 1.18
- Piotroski Score 5.00
- Grade Buy
- Symbol (BRX)
- Company Brixmor Property Group Inc.
- Price $29.26
- Changes Percentage (1.49%)
- Change $0.43
- Day Low $28.57
- Day High $29.28
- Year High $29.28
Brixmor (NYSE: BRX) is a real estate investment trust (REIT) that owns and operates a high-quality, national portfolio of open-air shopping centers. Its 395 retail centers comprise approximately 69 million square feet of prime retail space in established trade areas. The Company strives to own and operate shopping centers that reflect Brixmor's vision "to be the center of the communities we serve" and are home to a diverse mix of thriving national, regional and local retailers. Brixmor is a proud real estate partner to approximately 5,000 retailers including The TJX Companies, The Kroger Co., Publix Super Markets, Wal-Mart, Ross Stores and L.A. Fitness.
- Last Earnings 10/28/2024
- Ex-Dividend for 5/16 Dividend 01/03/2025
- Dividend Payable 01/15/2025
- Today N/A
- Next Earnings (Estimated) 02/10/2025
- Fiscal Year End N/A
- Average Stock Price Target $29.00
- High Stock Price Target $32.00
- Low Stock Price Target $26.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.93
- Trailing P/E Ratio 24.29
- Forward P/E Ratio 24.29
- P/E Growth 24.29
- Net Income $305.09 M
Income Statement
Quarterly
Annual
Latest News of BRX
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
The recent drop in prices must have disappointed Inhibrx Biosciences, Inc. (NASDAQ:INBX) institutional investors who own 43% of the shares
Inhibrx Biosciences has 7 investors with a majority stake of 50%. Institutions hold 43% ownership, facing the biggest gain or loss. Hedge funds and individuals also hold significant stakes, with Vikin...
By Yahoo! Finance | 1 day ago -
Brixmor Property Group Inc (BRX) Q3 2024 Earnings Call Highlights: Record Occupancy and ...
James Taylor, CEO, highlights positive outlook for external growth and institutional interest in retail market, justifying equity raise. Brian Finnegan, President, mentions strong tenant commitments a...
By Yahoo! Finance | 2 weeks ago -
Moleculin Biotech Inc (MBRX) Q2 2024 Earnings Call Highlights: Pivotal Phase 3 Trial for ...
The FDA meeting de-risked Annamycin's development for AML treatment, allowing higher dosing in the US. The MIRACLE Phase 3 trial has an adaptive design with a primary endpoint of complete remission....
By Yahoo! Finance | 1 month ago
